The Health path (02587) prices at HK$7.8 per share, Hong Kong public offering received 34.42 times oversubscribed.
The Road to Health (02587) announces the results of the distribution, with the company issuing 25 million H shares globally, and a public offering in Hong Kong...
HealthPath (02587) announced the results of its share allocation, with 25 million H shares sold globally. The public offering in Hong Kong accounted for 13.2% of the total, while the international allocation accounted for 86.8%. The final offering price was set at HK$7.8 per share, raising a net amount of approximately HK$109 million. Trading of the H shares is expected to commence on December 30, 2024, at 9:00 am on the Hong Kong Stock Exchange.
The public offering in Hong Kong was oversubscribed by 34.42 times, while the international allocation was oversubscribed by 0.98 times.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
